Stem Cell Research (May 2021)

Establishment of a human induced pluripotent stem cell line (WMUi031-A) from a Lowe syndrome patient carrying a OCRL gene mutation (c.2626dupA)

  • Rengchen Qian,
  • Long Wang,
  • Huihui Chen,
  • Yinjuan Ding,
  • Dexuan Wang,
  • Congde Chen,
  • Maoping Chu,
  • Xiaoou Shan,
  • Xiaoling Guo

Journal volume & issue
Vol. 53
p. 102294

Abstract

Read online

Lowe Syndrome (LS) is a rare X-linked multisystemic disorder syndrome, which can be caused by the gene mutations of OCRL. In present study, the urine cells (UCs) derived from a 12-year-old male LS patient with the hemizygote OCRL gene mutation p.M876N (c.2626dupA) were reprogrammed into induced pluripotent stem cells (iPSCs) named WMUi031-A through the commercial Sendai virus reprogramming kit. The pluripotent markers OCT4 and SOX2 can be expressed positively in WMUi031-A, which can be differentiated into three germ layers in vitro as well as maintain a stable karyotype (46, XY).